Drug resistance and use of long-acting ART

GenoTox Cell Counter: A mobile App to standardize cell counting in genotoxicity testing.

Genetics and molecular biology·2026

Programmatic effectiveness of tuberculosis preventive treatment for people with HIV in six high-tuberculosis-burden countries (PROTECT): a prospective cohort study and meta-analysis.

The lancet. HIV·2026

Morphine modulates doxorubicin-induced genomic instability with distinct effects in osteosarcoma and fibroblast cells.

Mutagenesis·2026

How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access.

Obesity (Silver Spring, Md.)·2026

Correlates of Dolutegravir Resistance in Low- and Middle-Income Countries: A Combined Analysis of Drug Resistance Surveys in Four Countries.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

The lancet. HIV·2026

Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care.

The lancet. HIV·2026

Expediting a UNIVERSAL first-line regimen of a dolutegravir-emtricitabine-tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1-2, pharmacokinetic, safety, and antiviral activity trial.

The lancet. HIV·2026

Targeted point-of-care HIV testing at birth for newborns at high risk of vertical transmission in Botswana: a prospective cohort study.

The lancet. HIV·2026

Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa.

The lancet. HIV·2026

Epidemiology and management of HIV-2.

The lancet. HIV·2026

Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.

The lancet. HIV·2026

The argument from the good lot.

Studies in history and philosophy of science·2026

Four eras of geriatric femoral neck fracture surgery: a bibliometric analysis of half-century research evolution and emerging frontiers.

Frontiers in surgery·2026

From rejection to formative development: recalibrating decisions for under-resourced authors.

ESMO real world data and digital oncology·2026

Experimental Sleep Restriction Blunts Positive Emotions and Aesthetic Experiences When Viewing Artwork.

Journal of sleep research·2026

The debiasing paradox: cognitive biases in judicial adjudication of valuation adjustment mechanisms across Chinese and American courts.

Frontiers in psychology·2026

The academic theatre of shadows: epistemological and ethical erosion in the era of marketing-based medicine.

Medicine, health care, and philosophy·2026

Related Experiment Videos

Drug resistance and use of long-acting ART

Related Concept Videos

GenoTox Cell Counter: A mobile App to standardize cell counting in genotoxicity testing.

Programmatic effectiveness of tuberculosis preventive treatment for people with HIV in six high-tuberculosis-burden countries (PROTECT): a prospective cohort study and meta-analysis.

Morphine modulates doxorubicin-induced genomic instability with distinct effects in osteosarcoma and fibroblast cells.

How Low Could Semaglutide Prices Fall? An Analysis of Production Cost and Implications for Global Access.

Correlates of Dolutegravir Resistance in Low- and Middle-Income Countries: A Combined Analysis of Drug Resistance Surveys in Four Countries.

Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus.

Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care.

Expediting a UNIVERSAL first-line regimen of a dolutegravir-emtricitabine-tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1-2, pharmacokinetic, safety, and antiviral activity trial.

Targeted point-of-care HIV testing at birth for newborns at high risk of vertical transmission in Botswana: a prospective cohort study.

Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa.

Epidemiology and management of HIV-2.

Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.

The argument from the good lot.

Four eras of geriatric femoral neck fracture surgery: a bibliometric analysis of half-century research evolution and emerging frontiers.

From rejection to formative development: recalibrating decisions for under-resourced authors.

Experimental Sleep Restriction Blunts Positive Emotions and Aesthetic Experiences When Viewing Artwork.

The debiasing paradox: cognitive biases in judicial adjudication of valuation adjustment mechanisms across Chinese and American courts.

The academic theatre of shadows: epistemological and ethical erosion in the era of marketing-based medicine.

Related Experiment Videos

Drug resistance and use of long-acting ART

Related Concept Videos

Related Articles